D. Filonenko

SDH-deficient gastrointestinal stromal tumors: paradoxical effect of imatinib

M. Nikulin, A. Meshcheryakov, E. Kolobanova, 2020 .

Ripretinib (DCC-2618): a new tyrosine kinase inhibitor for the treatment of metastatic gastrointestinal stromal tumors

A. Meshcheryakov, D. Filonenko, T. E. Tikhomirova, 2020 .

The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib

T. Semiglazova, I. Koroleva, I. Shlivko, 2021, Journal of Modern Oncology.

Antitumor response and quality of life: is there a need to sacrifice? Clinical observation: long-term and safe control of the disease using a combination of ribociclib with letrozole. Case report

K. Grechukhina, L. G. Zhukova, P. Tyutyunnik, 2022, Journal of Modern Oncology.

Unusual breast metastasis of gastrointestinal stromal tumor: A case report and literature review

N. Karnaukhov, L. Zhukova, D. Filonenko, 2023, World journal of clinical oncology.